Geriatrics News

Recent findings indicated individuals who were single or widowed had increased risk for dementia, compared with their married peers.

Speed of processing training decreased risk for dementia, while memory and reasoning training did not, according to recent findings.

Phase 2 findings indicated pimavanserin, a selective serotonin inverse agonist that targets 5-HT2A receptors, significantly reduced psychosis among patients with Alzheimer’s disease.

Otsuka Pharmaceutical/Lundbeck recently announced the initiation of a third phase 3 trial to determine efficacy of Rexulti for treatment of agitation in Alzheimer’s disease.

As November marks National Alzheimer’s Disease Awareness Month, the White House released a statement expressing commitment to cutting-edge research in Alzheimer’s disease.

Delayed neurological response to word processing may indicate increased risk for Alzheimer’s disease among individuals with mild cognitive impairment.

Donepezil was most effective at improving cognition in patients with Alzheimer’s dementia when compared with rivastigmine, galantamine, memantine and placebo, according to a systematic review and network meta-analysis published in the Journal of the American Geriatrics Society.

Research published in Sleep suggests that among adults aged 50 and older, the number of insomnia symptoms predicts 2-year fall risk, and that taking physician-recommended sleep medications increases fall risk, regardless of the presence of insomnia symptoms.

Recent findings showed accuracy of biomarker-based prognostic models for determining Alzheimer’s disease dementia and any type of dementia among patients with mild cognitive impairment.

Women who develop hypertension in their 40s had higher risk for developing dementia later in life, according to new data.